Leal Therapeutics raises $30 million in Series A financing led by SV Health Investors' Dementia Discovery Fund to develop therapies for neurodegenerative disorders.
Amount Raised
$30 Million
Round Type
Series A
WorcesterBiotechnologyHealth CareInvestors
Description
Leal Therapeutics, a biotechnology company, announced a $30 million Series A financing led by SV Health Investors' Dementia Discovery Fund. The funds will support clinical efficacy data for LTX-001 in schizophrenia and LTX-002 in ALS. The company aims to correct metabolic imbalances in the brain. Their novel approach is backed by extensive research and aims to address high unmet needs in CNS disorders.
Quick answer
Leal Therapeutics raised $30 Million in a Series A round, dated August 27, 2025. Investors: Chugai Venture Fund, Newpath Partners, Euclidean Capital, Orbimed, PhiFund, Alexandria Venture Investments and SV Health Investors' Dementia Discovery Fund. Leal Therapeutics is based in Worcester, Massachusetts, United States.
- How much did Leal Therapeutics raise?
- Leal Therapeutics raised $30 Million in a Series A round on August 27, 2025.
- Who invested in Leal Therapeutics?
- Chugai Venture Fund, Newpath Partners, Euclidean Capital, Orbimed, PhiFund, Alexandria Venture Investments and SV Health Investors' Dementia Discovery Fund are named as investors in this round.
- What does Leal Therapeutics do?
- Leal Therapeutics is a biotechnology company dedicated to developing novel neuro-metabolic therapeutics for patients with high-need central nervous system disorders.
- Where is Leal Therapeutics based and how big is it?
- Leal Therapeutics is based in Worcester, Massachusetts, United States. Fundz records about 30 employees.
- Who are the decision-makers at Leal Therapeutics?
- Fundz holds 4 contacts at Leal Therapeutics, including the Chief Technology Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Leal Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- ISOThrive raised $8.1M on October 10, 2025.
- ENDRA Life Sciences raised $14M on October 10, 2025.
- Expedition Therapeutics raised $165M (Series A) on October 9, 2025.
- Nerveli raised $540K (Pre-Seed) on October 9, 2025.
- Kneu Health raised $5.6M (Seed) on October 9, 2025.
- Fastest.Health raised $135K (Pre-Seed) on October 9, 2025.
Who to call at Leal Therapeutics, and when
A new round usually means Leal Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Leal Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Leal Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Leal Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Leal Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansLeal Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.